Scott Hirsch - 02 Jun 2026 Form 4 Insider Report for Keenova Therapeutics plc

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 02 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jun 2026, 16:13:23 UTC
Prior SEC filing: 25 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Mark Tyndall, Attorney-in-Fact

Key filing fact

Scott Hirsch filed Form 4 for Keenova Therapeutics plc on 04 Jun 2026.

Key facts

This page summarizes Scott Hirsch's Form 4 filing for Keenova Therapeutics plc.
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 04 Jun 2026, 16:13.

Change

Previous filing in this sequence was filed on 25 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002024619 Primary reporting owner

Hirsch Scott

Relationship: Director
Address: 440 ROUTE 22 EAST, SUITE 302, BRIDGEWATER
Signature: /s/ Mark Tyndall, Attorney-in-Fact
Signature date: 04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

No ticker transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +2,685
Change %: +590%
Price
Shares after: 3,140
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1

No ticker transaction

Ordinary Shares

Tax liability

Transaction value
Shares: -619
Change %: -20%
Price
Shares after: 2,521
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

No ticker transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares: -2,197
Change %: -25%
Price
Shares after: 6,669
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 2,197
Exercise price
Footnotes: F3, F4, F5

No ticker transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -2,685
Change %: -40%
Price: $0.000000^*
Shares after: 3,984
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 2,685
Exercise price
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Each restricted stock unit (the "RSU") that was settled, was settled in ordinary shares of the Issuer at one share per RSU.

Footnote F2

The number of ordinary shares withheld to satisfy tax withholding obligations arising out the vesting of RSUs is based on a percentage and did not take into account any market value as the Issuer's ordinary shares are not listed or quoted on a recognized trading market.

Footnote F3

The Reporting Person entered into an agreement with the Issuer pursuant to which the Reporting Person forfeited the right to receive 2,197 RSUs that would otherwise have vested in exchange for a payment from the Issuer to facilitate the Reporting Person's ability to satisfy certain tax obligations related to the RSUs scheduled to vest.

Footnote F4

The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders.

Footnote F5

The number of RSUs forfeited is based on a percentage.

SEC remarks

This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014.